Oncoimmunology., May 2015

Survivin-targeted Immunotherapy Drives Robust Polyfunctional T cell Generation and Differentiation in Advanced Ovarian Cancer Patients

Berinstein NL, Karkada M, Oza AM, Odunsi K, Villella JA, Nemunaitis JJ, Morse MA, Pejovic T, Bentley J, Buyse M, Nigam R, Weir GM, MacDonald LD, Quinton T, Rajagopalan R, Sharp K, Penwell A, Sammatur L, Burzykowski T, Stanford MM, Mansour M.

Vaccine, December 2014

Clearance of Depot Vaccine SPIO-labeled Antigen and Substrate Visualized Using MRI

Brewer KD, Lake K, Pelot N, Stanford MM, DeBay DR, Penwell A, Weir GM, Karkada M, Mansour M, Bowen CV.

OncoImmunology, November 2014

Metronomic Cyclophosphamide Enhances HPV16E7 Peptide Vaccine Induced Antigen-specific and Cytotoxic T-cell Mediated Antitumor Immune Response

Weir GM, Hrytsenko O, Stanford MM, Berinstein NL, Karkada M, Liwski RS, Mansour M.

J Trans Med., August 2012

First-in-man Application of a Novel Therapeutic Cancer Vaccine Formulation With the Capacity to Induce Multi-functional T Cell Responses in Ovarian, Breast and Prostate Cancer Patients

Berinstein NL, Karkada M, Morse MA, Nemunaitis JL, Chatta G, Kaufman H, Odunsi K, Nigam R, Sammatur L, MacDonald LD, Weir GM, Stanford MM, Mansour M.

Cancers, August 2011

Immune Modulation by Chemotherapy or Immunotherapy to Enhance Cancer Vaccinations

Weir GM, Liwski RS, Mansour M.